Clinical Trial Update: Oxytocin for Oxidative Stress and Inflammation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating oxytocin for oxidative stress and inflammation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation
• Oxidative Stress

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Florida Institute for Human and Machine Cognition | Conditions: Oxidative Stress, Inflammation | Phase 2 | Status: COMPLETED